Literature DB >> 30416366

A stereoselective synthesis of (-)-tetrahydrolipstatin.

Arun K Ghosh1, Chunfeng Liu1.   

Abstract

Entities:  

Year:  1999        PMID： 30416366      PMCID： PMC6223123          DOI： 10.1039/A904533C

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


× No keyword cloud information.
  5 in total

Review 1.  First clinical studies with orlistat: a short review.

Authors:  M L Drent; E A van der Veen
Journal:  Obes Res       Date:  1995-11

2.  Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.

Authors:  E K Weibel; P Hadvary; E Hochuli; E Kupfer; H Lengsfeld
Journal:  J Antibiot (Tokyo)       Date:  1987-08       Impact factor: 2.649

3.  The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase.

Authors:  P Hadváry; W Sidler; W Meister; W Vetter; H Wolfer
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

4.  Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase.

Authors:  S Hogan; A Fleury; P Hadvary; H Lengsfeld; M K Meier; J Triscari; A C Sullivan
Journal:  Int J Obes       Date:  1987

5.  Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin.

Authors:  P Hadváry; H Lengsfeld; H Wolfer
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857
  5 in total
  1 in total

1.  Leishmanicidal activity of aliphatic and aromatic lactones: correlation structure-activity.

Authors:  Marcela Castaño; Wilson Cardona; Winston Quiñones; Sara Robledo; Fernando Echeverri
Journal:  Molecules       Date:  2009-07-10       Impact factor: 4.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.